MAVACAMTEN: A door that has opened in the treatment of Hypertrophic Cardiomyopathy

被引：1
|
作者：
Hameed, Ishaque [1 ]
Siddiqui, Omer Mustafa [1 ]
Samad, Syed Abdus [2 ]
机构：
[1] Dow Univ Hlth & Sci, Civil Hosp, Dept Internal Med, Karachi, Pakistan
[2] Dow Univ Hlth & Sci, Civil Hosp, Dept Gen Surg, Karachi, Pakistan
来源：
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION | 2023年 / 73卷 / 02期
关键词：
D O I：
10.47391/JPMA.7258
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：446 / 447
页数：2
相关论文
共 50 条
  • [1] Mavacamten: treatment aspirations in hypertrophic cardiomyopathy
    Papadakis, Michael
    Basu, Joyee
    Sharma, Sanjay
    LANCET, 2020, 396 (10253): : 736 - 737
  • [2] Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    Rader, Florian
    Oreziak, Artur
    Choudhury, Lubna
    Saberi, Sara
    Fermin, David
    Wheeler, Matthew T.
    Abraham, Theodore P.
    Garcia-Pavia, Pablo
    Zwas, Donna R.
    Masri, Ahmad
    Owens, Anjali
    Hegde, Sheila M.
    Seidler, Tim
    Fox, Shawna
    Balaratnam, Ganesh
    Sehnert, Amy J.
    Olivotto, Iacopo
    JACC-HEART FAILURE, 2024, 12 (01) : 164 - 177
  • [3] Mavacamten for hypertrophic obstructive cardiomyopathy
    Quintana, Eduard
    Bajona, Pietro
    Myers, Patrick O.
    LANCET, 2021, 397 (10272): : 369 - 369
  • [4] Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy A Clinical Trial
    Heitner, Stephen B.
    Jacoby, Daniel
    Lester, Steven J.
    Owens, Anjali
    Wang, Andrew
    Zhang, David
    Lambing, Joseph
    Lee, June
    Semigran, Marc
    Sehnert, Amy J.
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (11) : 741 - +
  • [5] An evaluation of mavacamten for the treatment of symptomatic obstructive hypertrophic cardiomyopathy in adults
    Dong, Tiffany
    Nissen, Steven
    Ospina, Susan
    Desai, Milind Y.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (01) : 5 - 13
  • [6] Efficacy and safety of Mavacamten: A new era in the treatment of hypertrophic cardiomyopathy
    Sukaina, Mahnoor
    Waheed, Marium
    Ali, Naba
    Rasool, Raffat
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 106 : 144 - 146
  • [7] MAVACAMTEN IN HYPERTROPHIC CARDIOMYOPATHY: EFFECTIVE, BUT AFFORDABLE?
    Hanchate, Shivani
    Perry, Allison
    McClean, Karen
    Kramer, Christopher M.
    Ayers, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 713 - 713
  • [8] Mavacamten: A Novel Disease-Specific Treatment for Hypertrophic Cardiomyopathy
    Capilupi, Michael J.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2023, 31 (01) : 45 - 51
  • [9] Efficacy and Safety of Mavacamten in the Treatment of Hypertrophic Cardiomyopathy: A Systematic Review
    Bishev, Daniel
    Fabara, Stephanie
    Loseke, Isaac
    Alok, Akankcha
    Al-Ani, Hashim
    Bazikian, Yvette
    HEART LUNG AND CIRCULATION, 2023, 32 (09): : 1049 - 1056
  • [10] Mavacamten: A Novel Agent for Hypertrophic Cardiomyopathy
    Cole, J. Chase
    Benvie, Samantha F.
    DelosSantos, Marci
    CLINICAL THERAPEUTICS, 2024, 46 (04) : 368 - 373
12345